[1] Dong D, Tang L, Li Z Y, et al. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer[J]. Annals of Oncology, 2019, 30(3):431-438. [2] Wang Y, Liu W, Yu Y, et al. CT radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer[J]. European Radiology, 2020, 30(2):976-986. [3] Li J, Dong D, Fang M J, et al. Dual-energy CT-based deep learning radiomics can improve lymph node metastasis risk prediction for gastric cancer[J]. European Radiology, 2020, 30(4):2324-2333. [4] Zhang W J, Fang M J, Dong D, et al. Development and validation of a CT-based radiomic nomogram for preoperative prediction of early recurrence in advanced gastric cancer[J]. Radiotherapy and Oncology, 2020, 145:13-20. [5] Saito T, Kurokawa Y, Takiguchi S, et al. Accuracy of multidetector-row CT in diagnosing lymph node metastasis in patients with gastric cancer[J]. European Radiology, 2015, 25(2):368-374. [6] Clark D P, Lee C L, Kirsch D G, et al. Spectrotemporal CT data acquisition and reconstruction at low dose[J]. Medical Physics, 2015, 42(11):6317-6336. [7] 李祖银, 朱迪, 夏春华. 能谱CT扫描CT值、IC值在胃腺癌淋巴结定性评估中的临床应用[J]. 中国医药导报, 2021, 18(4):147-150, 183. [8] 王睿, 李靖, 梁盼, 等. 能谱CT术前预测胃腺癌淋巴结转移的价值[J]. 临床放射学杂志, 2019, 38(3):469-474. [9] 周岩, 王云, 杨晓晔, 等. 能谱CT用于胃癌术前肿瘤浸润深度和淋巴结转移的诊断价值研究[J]. 现代消化及介入诊疗, 2019, 24(12):1481-1484. [10] Lin M T, Song H J, Ding X Y. Long non-coding RNAs involved in metastasis of gastric cancer[J]. World Journal of Gastroenterology, 2018, 24(33):3724-3737. [11] Wei F, Wang Y, Zhou Y, et al. Long noncoding RNA CYTOR triggers gastric cancer progression by targeting miR-103/RAB10[J]. Acta Biochimica et Biophysica Sinica, 2021, 53(8):1044-1054. [12] Zhang H, Ma R R, Zhang G H, et al. Long noncoding RNA lnc-LEMGC combines with DNA-PKcs to suppress gastric cancer metastasis[J]. Cancer Letters, 2022, 524:82-90. [13] Yao F, Wang Q, Wu Q M. The prognostic value and mechanisms of lncRNA UCA1 in human cancer[J]. Cancer Management and Research, 2019, 11:7685-7696. [14] Yang A, Liu X, Liu P, et al. LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis[J]. Cellular & Molecular Biology Letters, 2021, 26(1):33. [15] Dai Q Q, Zhang T Q, Pan J M, et al. LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway[J]. Journal of Cancer, 2020, 11(13):3882-3892. [16] Dicken B J, Bigam D L, Cass C, et al. Gastric adenocarcinoma:Review and considerations for future directions[J]. Annals of Surgery, 2005, 241(1):27-39. [17] Yan S Y, Hu Y, Fan J G, et al. Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma[J]. World Journal of Gastroenterology, 2011, 17(11):1501-1506. [18] Bang Y J, Kang Y K, Kang W K, et al. Phase II study of sunitinib as second-line treatment for advanced gastric cancer[J]. Investigational New Drugs, 2011, 29(6):1449-1458. [19] 马轶, 梁青, 武婧, 等. 64排螺旋CT胃癌征象与病理分期及组织分化程度的相关性[J]. 医学影像学杂志, 2016, 26(5):824-828. [20] Liu S L, Liu S, Ji C F, et al. Application of CT texture analysis in predicting histopathological characteristics of gastric cancers[J]. European Radiology, 2017, 27(12):4951-4959. [21] Shen Y L, Kang H K, Jeong Y Y, et al. Evaluation of early gastric cancer at multidetector CT with multiplanar reformation and virtual endoscopy[J]. Radiographics:a Review Publication of the Radiological Society of North America, Inc, 2011, 31(1):189-199. [22] Meng X Y, Ni C, Shen Y Q, et al. Differentiating malignant from benign gastric mucosal lesions with quantitative analysis in dual energy spectral computed tomography:Initial experience[J]. Medicine, 2017, 96(2):e5878. [23] Pan Z L, Pang L F, Ding B, et al. Gastric cancer staging with dual energy spectral CT imaging[J]. PLoS One, 2013, 8(2):e53651. [24] Chen X H, Ren K, Liang P, et al. Spectral computed tomography in advanced gastric cancer:Can iodine concentration non-invasively assess angiogenesis?[J]. World Journal of Gastroenterology, 2017, 23(9):1666-1675. [25] Ba M C, Ba Z, Long H, et al. LncRNA AC093818.1 accelerates gastric cancer metastasis by epigenetically promoting PDK1 expression[J]. Cell Death & Disease, 2020, 11(1):64. [26] Schmitt A M, Chang H Y. Long noncoding RNAs in cancer pathways[J]. Cancer Cell, 2016, 29(4):452-463. [27] Niu J T, Song X X, Zhang X M. Regulation of lncRNA PVT1 on miR-125 in metastasis of gastric cancer cells[J]. Oncology Letters, 2020, 19(2):1261-1266. [28] Liu C M, Jin J, Shi J, et al. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer:A meta-analysis[J]. Bioscience Reports, 2019, 39(4):BSR20180995. [29] He A B, Hu R, Chen Z C, et al. Role of long noncoding RNA UCA1 as a common molecular marker for lymph node metastasis and prognosis in various cancers:A meta-analysis[J]. Oncotarget, 2017, 8(1):1937-1943. [30] Wang Y H, Wang F, Zhang L, et al. Long non-coding RNA UCA1 can predict tumor lymph node metastasis[J]. Tumour Biology, 2017, 39(5):1010428317706208. [31] Gong P H, Qiao F C, Wu H Z, et al. LncRNA UCA1 promotes tumor metastasis by inducing miR-203/ZEB2 axis in gastric cancer[J]. Cell Death & Disease, 2018, 9(12):1158. |